Metabolic supervision by PPIP5K, an inositol pyrophosphate kinase/phosphatase, controls proliferation of the HCT116 tumor cell line

Identification of common patterns of cancer metabolic reprogramming could assist the development of new therapeutic strategies. Recent attention in this field has focused on identifying and targeting signal transduction pathways that interface directly with major metabolic control processes. In the...

Full description

Saved in:
Bibliographic Details
Published inProceedings of the National Academy of Sciences - PNAS Vol. 118; no. 10; p. 1
Main Authors Gu, Chunfang, Liu, Juan, Liu, Xiaojing, Zhang, Haibo, Luo, Ji, Wang, Huanchen, Locasale, Jason W, Shears, Stephen B
Format Journal Article
LanguageEnglish
Published United States National Academy of Sciences 09.03.2021
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Identification of common patterns of cancer metabolic reprogramming could assist the development of new therapeutic strategies. Recent attention in this field has focused on identifying and targeting signal transduction pathways that interface directly with major metabolic control processes. In the current study we demonstrate the importance of signaling by the diphosphoinositol pentakisphosphate kinases (PPIP5Ks) to the metabolism and proliferation of the HCT116 colonic tumor cell line. We observed reciprocal cross talk between PPIP5K catalytic activity and glucose metabolism, and we show that CRISPR-mediated PPIP5K deletion suppresses HCT116 cell proliferation in glucose-limited culture conditions that mimic the tumor cell microenvironment. We conducted detailed, global metabolomic analyses of wild-type and PPIP5K knockout (KO) cells by measuring both steady-state metabolite levels and by performing isotope tracing experiments. We attribute the growth-impaired phenotype to a specific reduction in the supply of precursor material for de novo nucleotide biosynthesis from the one carbon serine/glycine pathway and the pentose phosphate pathway. We identify two enzymatic control points that are inhibited in the PPIP5K KO cells: serine hydroxymethyltransferase and phosphoribosyl pyrophosphate synthetase, a known downstream target of AMP-regulated protein kinase, which we show is noncanonically activated independently of adenine nucleotide status. Finally, we show the proliferative defect in PPIP5K KO cells can be significantly rescued either by addition of inosine monophosphate or a nucleoside mixture or by stable expression of PPIP5K activity. Overall, our data describe multiple, far-reaching metabolic consequences for metabolic supervision by PPIP5Ks in a tumor cell line.
Bibliography:Edited by Solomon H. Snyder, Johns Hopkins University School of Medicine, Baltimore, MD, and approved January 22, 2021 (received for review September 29, 2020)
Author contributions: C.G., J. Liu, X.L., H.Z., J. Luo, H.W., J.W.L., and S.B.S. designed research; C.G., J. Liu, X.L., H.Z., and H.W. performed research; C.G., J. Liu, X.L., H.Z., J. Luo, H.W., J.W.L., and S.B.S. analyzed data; and C.G., J. Liu, H.Z., H.W., and S.B.S. wrote the paper.
ISSN:0027-8424
1091-6490
DOI:10.1073/pnas.2020187118